Literature DB >> 769956

High-dose cyclophosphamide (NSC-26271) for recurrent or progressive ovarian adenocarcinoma.

M S Piver, J J Barlow, W S Chung.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 769956

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  2 in total

1.  Selecting dose-intense drug combinations: metastatic breast cancer.

Authors:  E L Korn; R Simon
Journal:  Breast Cancer Res Treat       Date:  1992-03       Impact factor: 4.872

2.  A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients.

Authors:  J P Eder; A D Elias; L Ayash; C A Wheeler; T C Shea; L E Schnipper; E Frei; K H Antman
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.